calendar
8,696 catalysts · 6,366 phase readout · 2,324 8k filing · 389 earnings · 3 pdufa · 2 approval · 1 adcom
next 91 dayslessmore
MonWedFri
8,696 catalysts · 6,366 phase readout · 2,324 8k filing · 389 earnings · 3 pdufa · 2 approval · 1 adcom
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Sudden Cardiac Death, Acute Myocardial Infarction
Sponsor: Northwell Health. Phase: PHASE1. Conditions: Treatment Resistant Depression
Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Septic Shock
Sponsor: Muhammad Aamir Latif. Phase: . Conditions: Clubfoot
Sponsor: Stanford University. Phase: NA. Conditions: Heart Failure
Sponsor: Medtronic Cardiovascular. Phase: NA. Conditions: Severe Tricuspid Regurgitation
Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Spinal Cord Injury
Sponsor: University Health Network, Toronto. Phase: NA. Conditions: Inspiratory Muscle Training
Sponsor: AbbVie. Phase: PHASE1. Conditions: Bipolar Disorder
Sponsor: VarmX B.V.. Phase: PHASE1. Conditions: Coagulation Disorder
Sponsor: Bayer. Phase: PHASE2. Conditions: Prostate Cancer
Sponsor: EndoQuest Robotics, Inc.. Phase: NA. Conditions: Colorectal Lesion, Colorectal Adenoma, Colorectal Polyp, Rectal Lesion, Rectal Adenoma, Rectal Polyp, Sigmoid; Lesion, Sigmoid Colon Polyp
Sponsor: University of Michigan. Phase: NA. Conditions: Inflammatory Bowel Diseases
Sponsor: Mayo Clinic. Phase: . Conditions: Glaucoma
Sponsor: National Institutes of Health Clinical Center (CC). Phase: . Conditions: Immunohematology
Sponsor: Fenerbahce University. Phase: NA. Conditions: Development Coordination Disorder, Motor Coordination or Function; Developmental Disorder, Sensory Integration Disorder, Perceived Stres Level, Cognitive Ability General
Sponsor: H. Lee Moffitt Cancer Center and Research Institute. Phase: NA. Conditions: Head and Neck Cancer
Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: Facial Paralysis
Sponsor: Jagiellonian University. Phase: NA. Conditions: Impact Molar, Mandible Cyst, Bone Regeneration, Platelet Rich Fibrin, Dentigerous Cyst, Dentin Matrix, Autogenous Dentin Graft, Demineralized Dentin Matrix, Impacted Lower Third Molar, Impacted Mandibular Third Molar
Sponsor: Massachusetts Eye and Ear Infirmary. Phase: NA. Conditions: Deafness, Cochlear Hearing Loss
Sponsor: Hospital Israelita Albert Einstein. Phase: NA. Conditions: Elderly
Sponsor: Universidad Complutense de Madrid. Phase: PHASE4. Conditions: Non-specific Low Back Pain (NSLBP), Facet Joint Syndrome
Sponsor: Hemerion Therapeutics. Phase: PHASE1. Conditions: Primary Glioblastoma
Sponsor: Hopital Foch. Phase: NA. Conditions: Surgical Operation With Transplant of Whole Organ
Sponsor: Annovis Bio Inc.. Phase: PHASE2. Conditions: Alzheimer's Dementia (AD)
Sponsor: Rohan Dharmakumar. Phase: . Conditions: Acute Myocardial Infarction
Sponsor: Beijing Biostar Pharmaceuticals Co., Ltd.. Phase: PHASE1. Conditions: Advanced Solid Tumor
Sponsor: Ottawa Heart Institute Research Corporation. Phase: PHASE2. Conditions: Diabetes Type 2, Coronary Artery Disease
Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Diffuse Large B-Cell Lymphoma, Refractory Hodgkin Lymphoma
Sponsor: Seoul National University Hospital. Phase: . Conditions: Kidney Transplantation, Graft Survival, Angiotensin II Type 1 Receptor Antibody
Sponsor: Vanderbilt University Medical Center. Phase: PHASE4. Conditions: Clubfoot
Sponsor: Haihua Yuan. Phase: PHASE2. Conditions: Solid Tumors, Neoplasms (Cancer / Tumors), Advanced Malignant Solid Neoplasm, Locally Advanced Malignant Solid Neoplasm, Unresectable Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, HER2 Expression, Biliary Tract Neoplasms, Endometrial Neoplasms, Urothelial Carcinoma (UC), Pancreatic Neoplasms, Colorectal Neoplasms, Gastric Neoplasms, Non-Small Cell Lung Carcinoma (NSCLC), Head and Neck Neoplasms, Cervical Neoplasms
Sponsor: University of California, San Francisco. Phase: NA. Conditions: Heart Diseases, Cardiovascular Disease
Sponsor: Wake Forest University Health Sciences. Phase: EARLY_PHASE1. Conditions: Central Centrifugal Cicatricial Alopecia
Sponsor: Nanchong Central Hospital. Phase: NA. Conditions: Colorectal Cancer, Leakage Testing, Colorectal Surgery, Complications, Anastomotic Leakage
Sponsor: Johns Hopkins Bloomberg School of Public Health. Phase: NA. Conditions: Nutrient Deficiency
Sponsor: C4 Therapeutics, Inc.. Phase: PHASE2. Conditions: Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Sponsor: Zai Lab (Shanghai) Co., Ltd.. Phase: PHASE1. Conditions: Solid Tumors, Sarcomas
Sponsor: Ferit Yetik. Phase: NA. Conditions: Postoperative Pain, Shoulder Arthroscopy
Sponsor: University Hospital, Basel, Switzerland. Phase: NA. Conditions: Pneumothorax, Pleural Effusion
Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Neurofibromatosis Type 1
Sponsor: National Cancer Institute (NCI). Phase: PHASE3. Conditions: Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v7
Sponsor: Chiesi Farmaceutica Ltda.. Phase: . Conditions: COPD (Chronic Obstructive Pulmonary Disease)
Sponsor: Alexandria University. Phase: NA. Conditions: Infraclavicular Vein Cannulation, Venous Cannulation
Sponsor: Novartis Pharmaceuticals. Phase: PHASE3. Conditions: Advanced HER2+Breast Cancer
Sponsor: Pontificia Universidad Catolica de Chile. Phase: NA. Conditions: Pediatric Anesthesia, Emergence Delirium, Anesthesia, Postoperative Pain, Tonsillectomy
Sponsor: Isabelle Herter-Aeberli. Phase: NA. Conditions: Bone, Bone Health
Sponsor: The University of Hong Kong. Phase: PHASE4. Conditions: Fontan, Heart Failure, Dapagliflozin, Cardiovascular Diseases, Sodium-GLucose coTransporter-2 Inhibitors
Sponsor: Janssen Research & Development, LLC. Phase: PHASE1. Conditions: Relapsed or Refractory Multiple Myeloma
Sponsor: Nantes University Hospital. Phase: . Conditions: Emergency Medical Service Communication Systems, Health Care